DarioHealth Corp. (DRIO) stock
Close on Nov 12, 2026Market cap $16.17MP/E 1.0Yield –
DarioHealth Corp. saw revenue fall 13.9% to $21.30M over the twelve months to Sep 30, 2026. Free cash flow was -$23.66M. At the latest close the market valued the company at $16.17M, 1.0 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $16.17M
- P/E ratio
- 1.0
- Price to sales
- 0.76
- Price to book
- 0.23
- Dividend yield
- –
- Free cash flow yield
- -146.30%
Fundamentals
- Revenue
- $21.30M
- Net income
- -$34.05M
- EPS, diluted
- $1.69
- Free cash flow
- -$23.66M
- Book value per share
- $5.91
- Diluted shares
- 12M
Trading
- Previous close
- $2.12
- Open
- $2.59
- Day's range
- $1.45 – $2.60
- Volume
- 152,217
- Average volume (20 days)
- 86,340
- Beta (5 years)
- 1.10
- 52-week range
- $1.45 – $14.77
- RSI (14 days)
- 20.4
- Volatility (1 year)
- 88.5%
- Relative volume
- 4.25×
- WACC
- 11.0%
Market cap history
Month-end market cap since 2013, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | DRIO | S&P 500 | Difference | DRIO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -69.6% | -2.7% | −66.9 pts | ||
| 3 months | -77.9% | -1.7% | −76.2 pts | ||
| Year to date | -85.5% | +11.9% | −97.4 pts | ||
| 1 year | -86.0% | +12.0% | −97.9 pts | ||
| 3 years | -92.3% | +78.2% | −170.5 pts | -57.4% | +21.2% |
| 5 years | -99.5% | +73.2% | −172.8 pts | -65.6% | +11.6% |
| 10 years | -97.3% | +309.6% | −407.0 pts | -30.4% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases DarioHealth filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- News
About DarioHealth
Surgical & Medical Instruments & Apparatus
Dario develops a digital health platform that combines proprietary hardware, artificial intelligence, and behavioral support to manage chronic conditions. Its offerings address health areas such as cardiometabolic care for diabetes and hypertension, weight management, musculoskeletal pain, and mental health issues including depression and anxiety. These solutions integrate connected medical devices, digital applications, personalized coaching, and virtual clinical care. The company serves individual consumers directly as well as institutional clients across several business segments, including medium-to-large employers, national and regional health plans, and global pharmaceutical manufacturers.
Company profile, executives and historyDarioHealth stock: common questions
What is DarioHealth's stock price?
DRIO closed at $1.65 on Nov 12, 2026, down 22.17% on the day. Over the past 52 weeks it traded between $1.45 and $14.77.
What is DarioHealth's market cap?
DarioHealth was worth $16.17M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is DRIO's P/E ratio?
DRIO trades at 1.0 times earnings, based on diluted earnings per share of $1.69 over the twelve months to Sep 30, 2026.
How much revenue does DarioHealth make?
DarioHealth reported revenue of $21.30M for the twelve months to Sep 30, 2026, down 13.9% from a year earlier.
Does DarioHealth pay a dividend?
No. DarioHealth has not paid a cash dividend over the last twelve months.
How has DRIO stock performed over the past year?
Including dividends, DRIO returned -86.0% over the past year, against +12.0% for the S&P 500.
How many DRIO shares are sold short?
0M shares were sold short at the latest FINRA report, 1.36% of the float, or 1.2 days of average trading volume.
Who are DarioHealth's competitors?
Companies most similar to DarioHealth by business, industry and size include BTCY, SNOA, BDMD, SRTS, BWAY.
See a number that looks wrong?